EPIDAREX CAPITAL
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, international corporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
EPIDAREX CAPITAL
Industry:
Angel Investment Life Science Venture Capital
Founded:
2010-01-01
Status:
Active
Contact:
301 298 5455
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Font Awesome Wordpress Plugins Microsoft Exchange Online Office 365 Mail
Current Employees Featured
Peter Finan Partner @ Epidarex Capital
Partner
2014-08-01
Elizabeth Roper Partner @ Epidarex Capital
Partner
2013-04-01
Kyparissia Sirinakis Founder & Managing Partner @ Epidarex Capital
Founder & Managing Partner
2010-10-01
Sinclair Dunlop Managing Partner @ Epidarex Capital
Managing Partner
2010-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-31 | Transine Therapeutics | Epidarex Capital investment in Seed Round - Transine Therapeutics | 4.6 M GBP |
| 2022-04-07 | Kynos Therapeutics | Epidarex Capital investment in Seed Round - Kynos Therapeutics | 6.5 M GBP |
| 2022-03-02 | Epsilogen | Epidarex Capital investment in Series B - Epsilogen | 30.75 M GBP |
| 2021-11-02 | Dunad Therapeutics | Epidarex Capital investment in Series A - Dunad Therapeutics | 24 M USD |
| 2021-10-21 | Leucid Bio | Epidarex Capital investment in Series A - Leucid Bio | 11.5 M GBP |
| 2021-07-29 | Topas Therapeutics | Epidarex Capital investment in Series B - Topas Therapeutics | 18 M EUR |
| 2021-07-29 | Macomics | Epidarex Capital investment in Seed Round - Macomics | 4.24 M GBP |
| 2021-06-23 | RapidPulse | Epidarex Capital investment in Series A - RapidPulse | 15 M USD |
| 2021-05-17 | Lunac Therapeutics | Epidarex Capital investment in Venture Round - Lunac Therapeutics | 4.75 M GBP |
| 2021-03-23 | Dunad Therapeutics | Epidarex Capital investment in Seed Round - Dunad Therapeutics | N/A |
More informations about "Epidarex Capital"
About Us – Epidarex
Epidarex Provides Equity Capital to Start-Ups, Including University Spin-outs Through our deep scientific and industry network we are able to identify transformative life science investments in …See details»
Epidarex Capital - Crunchbase Investor Profile & Investments
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and …See details»
Epidarex Capital - LinkedIn
Epidarex Capital is a leading transatlantic venture capital firm that invests in early-stage, high growth life science opportunities in under-ventured markets. Epidarex funds ground-breaking ...See details»
Strategy – Epidarex
We often partner with leading universities and research institutions to provide much needed capital for their most innovative ideas. Our aim is to build extraordinary companies that …See details»
Epidarex Capital investment portfolio - PitchBook
Epidarex Capital General Information Company Description. Founded in 2012, Epidarex Capital is a venture capital firm based in Bethesda, Maryland. The firm prefers to invest in the United …See details»
Epidarex Capital - Investments, Portfolio & Company Exits
Epidarex Capital 's most notable exits include Kynos Therapeutics, Apellis Pharmaceuticals, and Confluence Life Sciences. Which industries has this organization had the most exits in? Show …See details»
Epidarex Capital - Funding, Financials, Valuation & Investors
Epidarex Capital has raised a total of £47.5M across 2 funds, their latest being EPIDAREX CAPITAL III US. Announced Date . Fund Name . Money Raised . Dec 10, 2019: EPIDAREX …See details»
Epidarex Capital - LinkedIn
Epidarex Capital is a leading transatlantic venture capital firm that invests in early-stage, high growth life science opportunities in under-ventured markets. Epidarex funds ground-breaking …See details»
Transatlantic Epidarex banks $126M to back U.K. biotech startups
Jun 22, 2020 Epidarex Capital becomes the latest VC shop to close a major fund since the World Health Organization officially declared COVID-19 a pandemic, joining the likes of Atlas, …See details»
Member profile: Epidarex Capital | BIA - bioindustry.org
Oct 29, 2024 Epidarex Provides Equity Capital to Young Companies, Including University Spin-outs Our international management team has a track record of successfully partnering with …See details»
Henning Steinhagen | Epidarex Exeed
He is also co-founder and CEO of Epidarex Exeed, the therapeutic engine of Epidarex and acting as Venture Partner at Epidarex Capital. ... Previously, Henning served as President R&D at …See details»
Epidarex Capital Co-leads $29 Million Series A Financing in Newly ...
Sep 23, 2020 Libra Therapeutics is developing novel therapeutics for neurodegenerative diseases. BETHESDA, MD (US) and EDINBURGH (UK), September 23, 2020 – Epidarex …See details»
Epidarex Exeed founded by Epidarex Capital to advance early …
Edinburgh, UK, 09 December 2019 – Epidarex Capital, a leading transatlantic venture fund, today announced the launch of its therapeutic discovery engine, Epidarex Exeed Ltd. …See details»
Epidarex Capital II: Fund Performance - PitchBook
Apr 30, 2014 Epidarex Capital II is a 2013 vintage early stage venture capital fund managed by Epidarex Capital. The fund is located in Bethesda, Maryland and invests in the United …See details»
Epidarex Backs UK Startup Developing Emerging Anti …
Apr 8, 2022 In 2020, Epidarex Capital raised €112M to tap into unexplored life sciences expertise away from these typical hotspots. Kynos Therapeutics is the venture capital firm’s …See details»
Epidarex Capital Continues Expansion of its Team
Mar 22, 2019 Epidarex Capital, a leading early stage life science firm, ... (R&D) at Aptuit, a leading R&D organization. As an operational leader he led significant growth and …See details»
Epidarex Capital Creates Nodthera Limited - Nodthera
Edinburgh, Scotland, July 28, 2016: Epidarex Capital today announces the launch of Nodthera Limited, a new biotech company focused on the discovery and development of novel inhibitors …See details»
Epidarex Capital - Contacts, Employees, Board Members
Epidarex Capital has 5 current employee profiles, including Partner Peter Finan. Contacts. Edit Contacts Section. Job Department. Protected Content. Vice President Finance. Non …See details»
Paris dreams of becoming the capital of positive AI with the ...
23 hours ago France will host 100 heads of state and some 600 business and NGO leaders from the USA and Europe, as well as China and Africa.See details»
Epidarex Capital Invests in RapidPulse $15 Million Series A …
Jun 23, 2021 NEW EPIDAREX PORTFOLIO COMPANY WILL DEVELOP NOVEL CYCLIC ASPIRATION SYSTEM TO REMOVE BLOOD CLOTS FROM THE BRAIN. Bethesda, MD, …See details»